TAVI Sonrası Komplikasyonlar

Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of val-vular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 2022: 43 (7): 561–632.2.
Brunilda Alushi , Alexander Lauten, Umniye Balaban, et al. TAVI With or Without Predilation: Trends From a Large, Propensity-Score Weighted German Aortic Valve Registry (GARY) Population. J Invasive Cardiol. 2022 Dec;34(12): E841-E8493.
Marcus Thieme, Sven Moebius-Winkler, Marcus Franz, et al. Interventional Treatment of Access Site Complications During Transfemoral TAVI: A Single Center Experience. Front Cardiovasc Med. 2021 Nov 15:8: 725079.4.
Nicholas Sinclair, Alexa Mordhorst, Gary K Yang, et al. Vascular Access Complications and Clinical Outcomes of Vascular Surgical Repairs Following Transcatheter Aortic Valve Implantation (TAVI). Ann Vasc Surg. 2021 Jul:74: 258-263.5.
You-Jeong Ki, Jeehoon Kang, Hak Seung Lee, et al. Opti-mal Oversizing Index Depending on Valve Type and Lea-kage-Proof Function for Preventing Paravalvular Leakage after Transcatheter Aortic Valve Implantation. J Clin Med 2020 Dec 4;9(12): 39366.
Hagar A, Li Y, Wei X, et. Al. Incidence, predictors, and out-come of paravalvular leak after transcatheter aortic valve implantation. J Interv Cardiol 2020; May 22:2020:82494977.
van Rosendael, P.J., Delgado, V., Bax, J.J. Pacemaker implan-tation rate after transcatheter aortic valve implantation with early and new-generation devices: A systematic review. Eur. Heart J. 2018, 39, 2003–20138.
Antonios Halapas , Leonidas Koliastasis, Ioannis Doundou-lakis, et al. Transcatheter Aortic Valve Implantation and Conduction Disturbances: Focus on Clinical Implications. J Cardiovasc Dev Dis. 2023 Nov 19;10(11):469.9.
Bhardwaj, A., Ramanan, T., Sawant, A.C., et al. Quality of life outcomes in transcatheter aortic valve replacement patients requiring pacemaker implantation. J. Arrhythm.2018, 34, 441–449.
Kim HN, Yang DH, Park BE. Acute decompensated heart failure after transcatheter aortic valve implantation: A case report. Clin Case Rep. 2023 Jul 21;11(7): e7597.
D. J. van Ginkel, J. Brouwer, N. D. van Hemert, et al. Major threats to early safety after transcatheter aortic valve imp-lantation in a contemporary cohort of real-world patients. Neth Heart J. 2021 Dec;29(12): 632-642.
Myat A, Buckner L, Mouy F, Cockburn J, et al. In-hospital stroke after transcatheter aortic valve implantation: A UK observational cohort analysis. Catheter Cardiovasc Interv. 2021 Mar;97(4): E552-E559.
Manolis Vavuranakis, Konstantinos Kalogeras, Angelos Michail Kolokathis, et al. Antithrombotic therapy in TAVI. J Geriatr Cardiol. 2018 Jan; 15(1): 66–75.14.
Marc Najjar, Michael Salna & Isaac George. Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes. Expert Review of Cardiovascular Therapy, 13:3,301-316.15.
Liao YB, Deng XX, Meng Y, et al. Predictors and outcome of acute kidney injury after transcatheter aortic valve imp-lantation: a systematic review and meta-analysis. EuroInter-vention. 2017 Apr 20;12(17):2067-207416.
Sharaf-Eldin Shehada, Daniel Wendt, Davina Peters, et al. Infections after transcatheter versus surgical aortic valve replacement: mid-term results of 200 consecutive patients. J Thorac Dis. 2018 Jul; 10(7): 4342–4352.17.
Masanori Yamamoto, Toshiaki Otsuka, Tetsuro Shimura, et al. Incidence, Timing, and Causes of Late Bleeding After TAVR in an Asian Cohort. JACC Asia. 2022 Sep 6;2(5): 622-632.